ABSTRACT Progesterone treatment was found previously to reduce nuclear estrogen receptor (Re) rapidly (2-4 hr) in the hamster uterus in vivo. The present study was done to determine whether this inhibitory effect of progesterone on uterine nuclear Re could be demonstrated in vitro and whether progesterone action was dependent on RNA and protein synthesis. A uterine strip system was used in which estradiol pretreatment caused cytosol Re translocation to the nucleus and increased synthesis of cytosol progesterone receptor (Rp) during a 16-hr incubation. When progesterone was added to the medium 4 hr before the end of the incubation, cytosol Rp was depleted and nuclear Re was greatly reduced. Further experiments done with actinomycin D, puromycin, and cycloheximide indicated that the progesterone-induced loss of uterine nuclear Re was dependent on RNA and protein synthesis. These results suggest that progesterone reduced nuclear Re through a mechanism involving Rp translocation and the induction of RNA and protein synthesis, a product of which is active in degrading or otherwise inactivating nuclear Re.
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Estrogen-controlled changes in uterine structure and function are altered by subsequent exposure of the uterus to progesterone (1) . Recently, we discovered that progesterone action causes the rapid loss of nuclear estrogen receptor (Re) in the hamster uterus, a response that appeared to be mediated by the uterine progesterone receptor (Rp) system (2, 3) . This finding suggested that the progesterone-induced decline of uterine nuclear Re may be a fundamental mechanism for progesterone regulation of estrogen action.
The purpose of this study was to further investigate the nature of progesterone's influence on uterine nuclear Re. According to the receptor hypothesis for steroid hormone action, translocation of the hormone-receptor complex from the cytoplasm to the nucleus alters gene expression, with consequent changes in RNA and protein synthesis (4) . If progesterone acts through such a mechanism to cause the decline of nuclear Re, then inhibitors of RNA and protein synthesis should block the response of nuclear Re to progesterone action. A previously characterized in vitro uterine strip system was used to test this proposition (5, 6) . In this system, estrogen action stimulates the synthesis of cytoplasmic Rp, and progesterone treatment causes Rp translocation to the nucleus (6) . In the present study, the responsiveness of uterine strips to progesterone action was established by demonstrating that progesterone-induced Rp depletion was correlated with the rapid decline of nuclear Re. Then, through the use of the inhibitors actinomycin D, puromycin, and cycloheximide, it was determined that the progesterone-induced decline of nuclear Re was dependent on RNA and protein synthesis.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. 7.5 . Dextran/ charcoal suspension contained 0.5 g of Norit A (Sigma) and 50 mg of dextran-70 (Pharmacia) per 100 ml of buffer B. Scintillation counting solution was toluene/Triton X-100 (2:1, vol/vol) with 5 g of 2,5-diphenyloxazole and 50 mg of 1,4-bis-2-(5-phenyloxazolyl)-benzene per liter.
In Vitro Incubation. Animals were killed by cervical dislocation and uteri were removed rapidly, trimmed, slit lengthwise, weighed, and placed in 30-ml beakers under a 95% 02/5% CO2 atmosphere at 23°C in a Dubnoff incubator. Each beaker contained 5 ml of medium 199 and 2 uterine equivalents (ca. 200-250 mg). A typical experiment involved three groups of eight animals per group, and uterine strips derived from each group were divided equally among all experimental treatments. Each experiment was replicated at least three times.
The tissues were preincubated with estradiol (30 nM) for 1 hr at 23°C, rinsed, and transferred to 8 ml of fresh medium for a 12-hr incubation at 37°C. After 12 hr, tissues were transferred to fresh medium with or without progesterone (0.1 ,uM), and the incubation was continued for 4 hr. In experiments done to test the dependence of progesterone action on RNA and protein synthesis, inhibitors (10 ,ug of actinomycin D, puromycin, or Abbreviations: Re, estrogen receptor; Rp, progesterone receptor. * To whom reprint requests should be addressed.
Proc. Nati. Acad. Sci. USA 77 (1980) 5857 cycloheximide per ml of medium) were added 30 min before progesterone treatment. Incubations were terminated by transferring the tissues to ice-cold buffered saline. All further procedures were carried out at 0-20C except where specified.
Preparation of Cytosol and Nuclear KCI Extract. After incubation, the uterine strips from each incubation vessel were removed from the buffered saline, minced, and homogenized in 4 ml of buffer A.30, using a Polytron Pt-10 homogenizer (Brinkmann) as described (7). Cytoplasmic and nuclear fractions were prepared by centrifugation of the uterine homogenate at 800 X g for 15 min. The low-speed cytoplasmic fraction was centrifuged at 170,000 X g for 1 hr to yield the particle-free cytosol fraction. The nuclear-myofibrillar fraction was washed twice by resuspension in 4 ml of TG buffer and centrifugation at 800 X g for 15 min. The washed nuclear-myofibrillar pellet was resuspended in 4 ml of buffer A30 plus 0.5 M KCI and incubated for 1 hr with frequent mixing. Nuclear debris was removed by centrifugation at 170,000 X g for 1 hr to provide the nuclear KCI extract.
Assay of Cytosol and Nuclear Receptors. Receptor concentrations were determined -by Scatchard plot analysis of specific binding data (7, 8 [3H]progesterone (0.75-12 nM) for determination of total bound 3H-labeled ligand. Identical samples were incubated with either unlabeled diethylstilbestrol (1.4 ,M) or progesterone (4 AM) for determination of nonspecifically bound 3H-labeled ligand. Cytosol samples were incubated at 00C for 18 hr to measure unoccupied Re and total Rp. Nuclear extract was incubated at 00C for 24 hr to determine total nuclear Rp and at 30'C for 1 hr to measure total nuclear Re (3, 9) . After incubation of cytosol and nuclear extract, free and loosely bound steroid were removed from each sample by treatment with 500 Ml of dextran/charcoal suspension (10 min for Re; 30 see for Rp) followed by centrifugation at 1500 X g for 4 min. Radioactivity was measured in the supernatant fraction by liquid scintillation spectrophotometry using toluene/Triton counting solution at 38% counting efficiency. Measurement (Fig. IA) . Associated with the estradiol-induced increase in nuclear Re was an increase in cytosol Rp (Fig. 1B) . Progesterone treatment during the last 4 hr of incubation caused cytosol Rp depletion and a marked decrease in nuclear Re (Fig. IA) . The progesterone-mediated decline of nuclear Re was not accompanied by an increase in cytosol Re, which remained at or below the sensitivity limit of the assay (Fig. IA) . Thus, Re translocation in vitro was corre- Biochemistry: Evans (10) revealed that nuclear Re concentrations in groups treated with the inhibitors or the inhibitors plus progesterone were significantly (P < 0.01) higher than in the control group treated with progesterone alone. Progesterone had no significant effect on nuclear Re in groups treated with the inhibitors. Uterine strips were treated as described in Fig. 2 . At 30 min after addition of actinomycin D, puromycin, cycloheximide or saline/ethanol vehicle (control), progesterone (0.1 ,M) was added to all beakers.
The incubation was continued for 4 hr and then terminated. Nuclear Re and Rp concentrations were measured; each value represents the mean + SEM (n = 3). As in Fig. 2 , nuclear Re concentrations were higher (P < 0.05) in progesterone-treated uterine strips preincubated with RNA and protein synthesis inhibitors than in uterine strips treated with progesterone alone (control). In contrast, nuclear Rp concentrations were not influenced by actinomycin D or cycloheximide and were reduced slightly by puromycin. * P < 0.05, control vs. inhibitor.
incorporation by puromycin and cycloheximide, and [3H]leucine incorporation by actinomycin D, was less marked and about 30% in all cases. These results confirm the selective inhibitory action of these compounds on RNA and protein synthesis in the uterine strip system.
Experiments were done to determine whether the inhibitors would interfere with the progesterone-induced reduction of nuclear Re. The effect of inhibitor alone was evaluated, and actinomycin D and puromycin did not significantly influence nuclear Re (Fig. 2) . Cycloheximide decreased nuclear Re, but not to as great an extent as the reduction observed in response to progesterone action. However, when inhibitor and progesterone treatments were combined, the decline of nuclear Re attributable to progesterone action was blocked effectively by all three inhibitors. The inhibitors had no effect on progesterone-stimulated cytosol Rp depletion (data not shown), and they had little, if any, influence on the retention of nuclear Rp at 4 hr after progesterone treatment (Table 2) . Because the inhibitors did not block progesterone action by interfering with either cytosol Rp translocation or nuclear Rp retention, these results support the conclusion that the progesterone-induced loss of nuclear Re was dependent on RNA and protein synthesis. DISCUSSION Previous experiments done in vivo with intact animals and ovariectomized, hormonally treated, animals established an early inhibitory effect of progesterone on nuclear Re in the hamster uterus (2, 3) . The progesterone-induced loss of nuclear Re was not dependent on circulating estradiol levels or the availability of cytosol Re for translocation. The steroid specificity and progesterone dose dependency of the nuclear Re response indicated participation of the Rp system (3). In subsequent experiments, the effect of progesterone on uterine uptake and retention of [3H]estradiol was studied. Progesterone had no effect on the uptake of [3H]estradiol by the nuclear fraction, but progesterone reduced significantly the amount of [3H]estradiol retained by the nuclear fraction at 4 hr after treatment. t Because there was no evidence for the recycling of nuclear Re to the cytoplasm, progesterone appeared to stimulate the degradation or inactivation of Re in the nucleus. The present results extend our previous observations and suggest t (Table 2) , this progesterone-controlled process appears to be specific for nuclear Re. A mechanism for progesterone reduction of nuclear Re has emerged that is consistent with the generally accepted mechanism of steroid hormone action (4) . Estrogen action stimulates the synthesis and accumulation of cytosol Rp, and Rp is translocated to the nucleus in response to progesterone (Fig. 3) . Interaction of the progesterone-Rp complex with chromatin alters gene expression and stimulates RNA and protein synthesis. A product of this macromolecular synthesis (i.e., a regulatory factor) acts either directly on nuclear Re or indirectly through the activation of a mediator.
The nature of the proposed regulatory factor stimulated by progesterone action is not known. Calcium-activated proteases that partially degrade Re and Rp have been isolated from the calf uterus and chick oviduct (12, 13 In the rat uterus, progesterone inhibits cytosol Re replenishment measured 12-24 hr after combined estradiol and progesterone treatment (14) . Progesterone reduction of cytosol Re levels was proposed to account for diminished nuclear Re and uterine responsiveness to further estradiol stimulation (15 Fig. 2 ). This observation argues against the notion that inhibition of cytosol Re production accounts for the decline of nuclear Re. In view of the correlation between nuclear Re retention and the response of the rat uterus to estrogen action (18, 19) , we suggest that progesterone inhibition of estrogen-stimulated cytosol Re replenishment proceeds through a primary inhibitory effect of progesterone on nuclear Re.
The present results support the idea that the hormonal control of receptor degradation in the nucleus is a mechanism that regulates the cell response to hormone action, However, loss of receptor from the nucleus does not necessarily indicate a reduced hormone response. Horwitz and McGuire (20) have described nuclear "processing" of Re, manifested by the decline of nuclear Re, which appears to be associated with estrogen action in cultured MCF-7 cells. Furthermore, nuclear Re processing, and hence estrogen action, was inhibited by actinomycin D (21) or anti-estrogen treatment (22) . Processing of nuclear Re has also been described in suspensions of uterine cells (23) . It is conceivable that uterine Re retained in the nuclear fraction for an extended period represents unprocessed receptor. Progesterone action, in causing decreased nuclear Re retention, may activate nuclear Re processing held in abeyance during estrogen stimulation. Thus, the progesterone-induced loss of nuclear Re may have either an inhibitory or a stimulatory effect on estrogen action. Clarification of this issue requires further study to determine the relationship of nuclear Re retention and processing to the expression of estrogen action.
In summary, progesterone reduction of nuclear Re appears to proceed through Rp translocation and the stimulation of RNA and protein synthesis. Nuclear Re response to progesterone action is rapid and may be an important first step in the control of estrogen action by progesterone in the uterus.
